During the quarter, revenue from the domestic business was ₹280 crore, a growth of 8% YoY. The revenue from the export business was ₹1,076 crore, a growth of 19% YoY.
The recovery in domestic business was aided by good Rabi season.
The trend of elevated costs continued during the quarter. This was partially mitigated by price hike in both the CSM (custom synthesis and manufacturing) exports and domestic segment. The full impact of price hike will get reflected in the coming quarters.
The contraction in EBITDA margin was due to increased overhead cost mainly attributable to sharp increase in fuel and related utilities, logistic cost and one-time expenses pertaining to strategic initiatives.
During the quarter, the company commercialized 4 new molecules. It also commercialized new chemistry building block (MMH) in the CSM segment.
Few of its newly launched products like Awkira, PB Knot and Armatura witnessed good traction.
It continued to maintain higher level of inventory of ₹1,355 crore to avert supply chain disruptions and meet customer supply schedules and continued operations. It continued to maintain its strong liquidity position with surplus cash net of debt at ₹2,078 crore including QIP (qualified institutional placement) proceeds.
The recovery in domestic business was aided by good Rabi season.
The trend of elevated costs continued during the quarter. This was partially mitigated by price hike in both the CSM (custom synthesis and manufacturing) exports and domestic segment. The full impact of price hike will get reflected in the coming quarters.
The contraction in EBITDA margin was due to increased overhead cost mainly attributable to sharp increase in fuel and related utilities, logistic cost and one-time expenses pertaining to strategic initiatives.
During the quarter, the company commercialized 4 new molecules. It also commercialized new chemistry building block (MMH) in the CSM segment.
Few of its newly launched products like Awkira, PB Knot and Armatura witnessed good traction.
It continued to maintain higher level of inventory of ₹1,355 crore to avert supply chain disruptions and meet customer supply schedules and continued operations. It continued to maintain its strong liquidity position with surplus cash net of debt at ₹2,078 crore including QIP (qualified institutional placement) proceeds.